Related Experiment Video
Updated: May 23, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Subepicardial adipose genes contribute to the deterioration of heart failure preserved ejection fraction
Ruiying Zhang1,2,3, Man Wang3,4,5, Yuheng Lang6,7
1Department of Emergency and Critical Care, Tianjin University Chest Hospital, Tianjin, China.
Insights
Obesity contributes to heart failure with preserved ejection fraction (HFpEF). This study identifies OGN, FOS, and ALOX5 as key genes involved in cell senescence and HFpEF progression, offering potential therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Genomics
Background:
- Rising mortality from acute myocardial infarction (MI) linked to obesity.
- Obesity as a major driver of coronary artery disease (CAD) progression.
- Obesity-induced heart failure with preserved ejection fraction (HFpEF) mechanisms remain unclear.
Purpose of the Study:
- To identify visceral adipocyte-associated genes in heart failure.
- To investigate the role of these genes in HFpEF pathogenesis.
- To explore potential therapeutic targets for HFpEF.
Main Methods:
- Venn diagram analysis of visceral adipocyte genes and differentially expressed genes (DEGs).
- Protein-protein interaction (PPI) network construction to identify hub genes.
- Validation using single-cell sequencing, cell lines, and human tissue samples.
Main Results:
- Identified 71 visceral adipocyte-associated DEGs and nine hub genes, including OGN, FOS, and ALOX5.
- Hub genes showed high expression in end-stage heart failure and HFpEF patients.
- OGN, FOS, and ALOX5 demonstrated diagnostic potential for HFpEF with high AUC values.
Conclusions:
- OGN, FOS, and ALOX5 are validated as key genes in HFpEF.
- These genes are implicated in hypoxia-induced cell senescence.
- OGN, FOS, and ALOX5 represent potential therapeutic targets for HFpEF and prediction of disease progression.
Background:
The mortality of patients with acute myocardial infarction (MI) raised rapidly in last decade and obesity are becoming the major cause to CAD progression, thus inducing heart failure preserved ejection fraction (HFpEF). However, why visceral adipocytes show different effects on healthy and ageing cardiomyocytes is less known.
Methods:
GSE251971 was downloaded and Venn diagram between visceral adipocyte genes genes and DEGs was performed to obtain visceral adipocyte-associated DEGs in heart failure. Protein-protein interaction (PPI) network was constructed to obtain the hub genes utilizing the Cytoscape plugin Cytohubba. The hub genes and their interactions were analyzed using NetworkAnalyst 3.0 and for validation, the hub genes expressions were analyzed using Single-cell sequencing data, cell lines and human sub-epicardial tissues and blood samples.
Results:
Using Venn diagram, 71 visceral adipocyte-associated DEGs were identified. Nine hub genes were obtained, including OGN, SELL, FOS, NKG7, LOX, HBB, CXCL9, CP and ALOX5. Single-cell sequencing demonstrated all hub genes were highly expressed in human hypertrophic cardiomyopathy and ischemic cardiomyopathy patients with end-stage heart failure. The related OGN, FOS, NKG7 and ALOX5 mRNA expressions were significantly highly expressed in sub-epicardial tissues in HFpEF patients. AUCs of OGN, FOS and ALOX5 were 0.902, 0.795 and 0.730, and the AUC of joint ROC of OGN, FOS and ALOX5 was 0.946. Additionally, FOS, ALOX5 and OGN expressions were increased at follow up 1 year recurrence, while decreased at follow up 2 year recurrence. Mechanically, FOS and ALOX5 were highly expressed in macrophages under hypoxia, while OGN was highly expressed in fibroblasts under hypoxia. SASPs, including IL1α, IL1β, IL6 and TNFα, decreased in hypoxic macrophages after FOS and ALOX5 knockdown or both. Also, SASPs decreased in hypoxic fibroblasts after OGN knockdown. These results suggested that FOS, ALOX5 and OGN may affect cell senescence after hypoxia, thus inducing myocardial infarction and HFpEF progression.
Conclusion:
The screened hub genes, including OGN, FOS and ALOX5, were validated using single-cell sequencing data, cell lines and human samples, which can be therapeutic targets for the treatment to cell senescence under hypoxia and prediction to heart failure progression to HFpEF.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers

